These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

402 related articles for article (PubMed ID: 2333829)

  • 21. Cushing's syndrome caused by topical steroid therapy for psoriasis.
    Abma EM; Blanken R; De Heide LJ
    Neth J Med; 2002 Apr; 60(3):148-50. PubMed ID: 12164372
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effects of glucocorticoids on the hypothalamic-pituitary-adrenal axis in children and adults.
    Gulliver T; Eid N
    Immunol Allergy Clin North Am; 2005 Aug; 25(3):541-55, vii. PubMed ID: 16054542
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Assessment of value and risks of external treatment with clobetasol-17-propionate (Dermovate)].
    van der Harst LC; Smeenk G; Burger PM; van der Rhee HJ; Polano MK
    Ned Tijdschr Geneeskd; 1978 Feb; 122(7):219-23. PubMed ID: 345134
    [No Abstract]   [Full Text] [Related]  

  • 24. [Emovate in dermatological practice].
    Bigliardi P
    Ther Umsch; 1984 Jun; 41(6):425-8. PubMed ID: 6463911
    [No Abstract]   [Full Text] [Related]  

  • 25. Clobetasol propionate followed by calcipotriol is superior to calcipotriol alone in topical treatment of psoriasis.
    Austad J; Bjerke JR; Gjertsen BT; Helland S; Livden JK; Morken T; Mørk NJ
    J Eur Acad Dermatol Venereol; 1998 Jul; 11(1):19-24. PubMed ID: 9731961
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Concurrent application of tretinoin (retinoic acid) partially protects against corticosteroid-induced epidermal atrophy.
    McMichael AJ; Griffiths CE; Talwar HS; Finkel LJ; Rafal ES; Hamilton TA; Voorhees JJ
    Br J Dermatol; 1996 Jul; 135(1):60-4. PubMed ID: 8776360
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Hypothalamic-pituitary-adrenal function in children with asthma and rhinitis treated with topical glucocorticosteroids.
    Wolthers OD; Honour JW
    Clin Exp Allergy; 1998 May; 28(5):545-50. PubMed ID: 9645590
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Selective evaluation of a new topical steroid (betamethasone benzoate).
    Cullen SI
    Curr Ther Res Clin Exp; 1973 May; 15(5):243-7. PubMed ID: 4267808
    [No Abstract]   [Full Text] [Related]  

  • 29. [Diprosone cream: its value in daily dermatologic practice].
    Lille Med; 1975 Jan; 20(1):61-3. PubMed ID: 1134174
    [No Abstract]   [Full Text] [Related]  

  • 30. Atrophic skin striae following the use of clobetasol propionate ointment.
    Hardie RA; Waring AJ; Barnetson RS
    Practitioner; 1977 Sep; 219(1311):376-8. PubMed ID: 928283
    [No Abstract]   [Full Text] [Related]  

  • 31. The safety of halobetasol 0.05% ointment in the treatment of psoriasis.
    Watson WA; Kalb RE; Siskin SB; Freer JP; Krochmal L
    Pharmacotherapy; 1990; 10(2):107-11. PubMed ID: 2349135
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The role of clobetasol propionate emollient 0.05% in the treatment of patients with dry, scaly, corticosteroid-responsive dermatoses.
    Gordon ML
    Clin Ther; 1998; 20(1):26-39. PubMed ID: 9522102
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Lichen sclerosus of the vulva. Long-term steroid maintenance therapy.
    Sinha P; Sorinola O; Luesley DM
    J Reprod Med; 1999 Jul; 44(7):621-4. PubMed ID: 10442326
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cushing's syndrome and adrenal suppression from percutaneous absorption of clobetasol propionate in infants.
    Cherian MP; AbdulJabbar M
    Saudi Med J; 2001 Dec; 22(12):1139-41. PubMed ID: 11802195
    [No Abstract]   [Full Text] [Related]  

  • 35. Hypothalamic-pituitary-adrenal axis suppression related to topical glucocorticoid therapy in a child with psoriatic exfoliative erythroderma.
    Campbell LS; Chevalier M; Levy RA; Rhodes A
    Pediatr Dermatol; 2012; 29(1):101-4. PubMed ID: 21995486
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Treatment of dermatological conditions with a combination of an antibacterial agent, an antifungal agent and an antiinflammatory steroid.
    Franchi G
    Int J Clin Pharmacol Ther Toxicol; 1985 Sep; 23(9):488-90. PubMed ID: 4055161
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clobetasol propionate 0.05% under occlusion in the treatment of alopecia totalis/universalis.
    Tosti A; Piraccini BM; Pazzaglia M; Vincenzi C
    J Am Acad Dermatol; 2003 Jul; 49(1):96-8. PubMed ID: 12833016
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Plasma cell vulvitis and response to topical steroids: a case report.
    David L; Massey K
    Int J STD AIDS; 2003 Aug; 14(8):568-9. PubMed ID: 12935388
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Halogenation and topical corticosteroids: a comparison between the 17-butyrate esters of hydrocortisone and clobetasone in ointment bases.
    Allenby CF; Sparkes CG
    Br J Dermatol; 1981 Feb; 104(2):179-83. PubMed ID: 7011356
    [TBL] [Abstract][Full Text] [Related]  

  • 40. An infantile Cushing syndrome due to misuse of topical steroid.
    Siklar Z; Bostanci I; Atli O; Dallar Y
    Pediatr Dermatol; 2004; 21(5):561-3. PubMed ID: 15461763
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.